NDC 24286-1552

PURGASOL

Sennosides Docusate Sodium

PURGASOL is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Dlc Laboratories, Inc.. The primary component is Sennosides; Docusate Sodium.

• Product ID: 24286-1552_2ce98863-b53b-4729-a76d-7b602a306182
• NDC: 24286-1552
• Product Type: Human Otc Drug
• Proprietary Name: PURGASOL
• Generic Name: Sennosides Docusate Sodium
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2009-11-16
• Marketing Category: OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
• Application Number: part334
• Labeler Name: DLC Laboratories, Inc.
• Substance Name: SENNOSIDES; DOCUSATE SODIUM
• Active Ingredient Strength: 9 mg/1; mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 24286-1552-6

1 BOTTLE in 1 BOX (24286-1552-6) > 60 TABLET in 1 BOTTLE

• Marketing Start Date: 2009-11-16
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 24286-1552-6 [24286155206]

PURGASOL TABLET

• Marketing Category: OTC monograph not final
• Application Number: part334
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2009-11-16

Drug Details

Active Ingredients

Ingredient	Strength
SENNOSIDES	8.6 mg/1

OpenFDA Data

• SPL SET ID: 388c41ab-8574-408d-80b0-7abc1b3ca630
• Manufacturer:
  • DLC Laboratories, Inc.
• UNII:
  • F05Q2T2JA0
  • 3FYP5M0IJX
• RxNorm Concept Unique ID - RxCUI:
  • 1248011
  • 998740